Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;61(6):847-54.
doi: 10.1136/gutjnl-2011-300865. Epub 2012 Mar 17.

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

Affiliations

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

Mai Yamauchi et al. Gut. 2012 Jun.

Abstract

Objective: Colorectal cancer is typically classified into proximal colon, distal colon and rectal cancer. Tumour genetic and epigenetic features differ by tumour location. Considering a possible role of bowel contents (including microbiome) in carcinogenesis, this study hypothesised that tumour molecular features might gradually change along bowel subsites, rather than change abruptly at splenic flexure.

Design: Utilising 1443 colorectal cancers in two US nationwide prospective cohort studies, the frequencies of molecular features (CpG island methylator phenotype (CIMP), microsatellite instability (MSI), LINE-1 methylation and BRAF, KRAS and PIK3CA mutations) were examined along bowel subsites (rectum, rectosigmoid junction, sigmoid, descending colon, splenic flexure, transverse colon, hepatic flexure, ascending colon and caecum). The linearity and non-linearity of molecular relations along subsites were statistically tested by multivariate logistic or linear regression analysis.

Results: The frequencies of CIMP-high, MSI-high and BRAF mutations gradually increased from the rectum (<2.3%) to ascending colon (36-40%), followed by falls in the caecum (12-22%). By linearity tests, these molecular relations were significantly linear from rectum to ascending colon (p<0.0001), and there was little evidence of non-linearity (p>0.09). Caecal cancers exhibited the highest frequency of KRAS mutations (52% vs 27-35% in other sites; p<0.0001).

Conclusions: The frequencies of CIMP-high, MSI-high and BRAF mutations in cancer increased gradually along colorectum subsites from the rectum to ascending colon. These novel data challenge the common conception of discrete molecular features of proximal versus distal colorectal cancers, and have a substantial impact on clinical, translational and epidemiology research, which has typically been performed with the dichotomous classification of proximal versus distal tumours.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None

Figures

Figure 1
Figure 1
Frequencies of CIMP-high, MSI-high, and BRAF mutation in colorectal cancer along bowel subsites. The frequencies of these molecular features increase gradually from rectum to ascending colon. Formal multivariate statistical analyses for linearity and non-linearity were performed as described in MATERIALS AND METHODS and results are shown in Table 4. CIMP, CpG island methylator phenotype; MSI, microsatellite instability.
Figure 2
Figure 2
Frequencies of CIMP/MSI subtypes of colorectal cancer along bowel subsites. The frequency of CIMP-high MSI-high tumors increased gradually from rectum to ascending colon, while that of CIMP-low/0 MSS tumors decreased gradually from rectum to ascending colon. CIMP, CpG island methylator phenotype; MSI, microsatellite instability; MSS, microsatellite stable.

Similar articles

Cited by

References

    1. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779–88. - PubMed
    1. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101:403–8. - PubMed
    1. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol. 2004;88:261–6. - PubMed
    1. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011;60:397–411. - PMC - PubMed
    1. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut. 2011;60:116–29. - PMC - PubMed

Publication types

MeSH terms